Birdwatch Note
2023-04-02 16:22:40 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
There is no evidence provided for the claim that 200,000 Americans lost their lives due to vaccine hesitancy. Given the modest protection of the covid mRNA vaccine and the problematic side effects this is pure conjecture. https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v1.full https://www.medrxiv.org/content/medrxiv/early/2022/12/19/2022.12.17.22283625/F2.large.jpg
Written by 386CBA97FA2604BB5BFB206F36315DCC46BA97CE97CBFEFADC262EEDFBA93D1A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1642484153143664645
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1642563207184146435
- noteId - 1642563207184146435
- participantId -
- noteAuthorParticipantId - 386CBA97FA2604BB5BFB206F36315DCC46BA97CE97CBFEFADC262EEDFBA93D1A Participant Details
- createdAtMillis - 1680452560598
- tweetId - 1642484153143664645
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- There is no evidence provided for the claim that 200,000 Americans lost their lives due to vaccine hesitancy. Given the modest protection of the covid mRNA vaccine and the problematic side effects this is pure conjecture. https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v1.full https://www.medrxiv.org/content/medrxiv/early/2022/12/19/2022.12.17.22283625/F2.large.jpg
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-04-02 16:22:40 UTC (1680452560598) |
1969-12-31 23:59:59 UTC (-1) |
2023-04-03 02:39:46 UTC (1680489586224) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-04-02 19:21:05 -0500 | Rating Details | |
2023-04-02 19:20:41 -0500 | Rating Details | |
2023-04-02 18:06:34 -0500 | Rating Details | |
2023-04-02 17:54:49 -0500 | Rating Details | |
2023-04-02 17:49:36 -0500 | Rating Details | |
2023-04-02 17:03:26 -0500 | Rating Details | |
2023-04-02 16:46:11 -0500 | Rating Details | |
2023-04-02 14:36:38 -0500 | Rating Details | |
2023-04-02 14:17:23 -0500 | Rating Details | |
2023-04-02 13:44:37 -0500 | Rating Details | |
2023-04-02 13:32:12 -0500 | Rating Details | |
2023-04-02 13:26:44 -0500 | Rating Details | |
2023-04-02 13:21:36 -0500 | Rating Details | |
2023-04-02 12:58:14 -0500 | Rating Details | |
2023-04-02 12:56:00 -0500 | Rating Details | |
2023-04-02 12:00:15 -0500 | Rating Details | |
2023-04-02 11:37:39 -0500 | Rating Details | |
2023-04-02 11:35:45 -0500 | Rating Details | |
2023-04-02 11:29:12 -0500 | Rating Details | |
2023-04-02 11:26:12 -0500 | Rating Details | |
2023-04-03 06:07:16 -0500 | Rating Details | |
2023-04-03 05:51:40 -0500 | Rating Details | |
2023-04-03 00:45:37 -0500 | Rating Details | |
2023-04-02 23:52:06 -0500 | Rating Details | |
2023-04-02 22:46:02 -0500 | Rating Details | |
2023-04-02 22:37:11 -0500 | Rating Details | |
2023-04-02 22:26:35 -0500 | Rating Details | |
2023-04-02 22:02:57 -0500 | Rating Details | |
2023-04-02 21:20:04 -0500 | Rating Details | |
2023-04-02 21:14:40 -0500 | Rating Details | |
2023-04-02 21:05:54 -0500 | Rating Details | |
2023-04-02 20:27:03 -0500 | Rating Details | |
2023-04-02 20:26:21 -0500 | Rating Details | |
2023-04-02 20:21:03 -0500 | Rating Details | |
2023-04-02 19:45:26 -0500 | Rating Details | |
2023-04-03 13:27:21 -0500 | Rating Details | |
2023-04-03 10:55:32 -0500 | Rating Details | |
2023-04-03 08:44:43 -0500 | Rating Details | |
2023-04-02 14:17:23 -0500 | Rating Details | |
2023-04-02 22:46:02 -0500 | Rating Details | |
2023-04-02 13:26:44 -0500 | Rating Details | |
2023-04-03 10:55:32 -0500 | Rating Details | |
2023-04-03 00:45:37 -0500 | Rating Details | |
2023-04-03 13:27:21 -0500 | Rating Details | |
2023-04-02 13:21:36 -0500 | Rating Details | |
2023-04-02 19:21:05 -0500 | Rating Details | |
2023-04-02 20:27:03 -0500 | Rating Details | |
2023-04-02 19:20:41 -0500 | Rating Details | |
2023-04-02 11:35:45 -0500 | Rating Details | |
2023-04-02 12:56:00 -0500 | Rating Details | |
2023-04-02 18:06:34 -0500 | Rating Details | |
2023-04-02 23:52:06 -0500 | Rating Details | |
2023-04-02 22:37:11 -0500 | Rating Details | |
2023-04-02 22:02:57 -0500 | Rating Details | |
2023-04-02 16:46:11 -0500 | Rating Details | |
2023-04-02 21:05:54 -0500 | Rating Details | |
2023-04-02 13:32:12 -0500 | Rating Details | |
2023-04-02 17:49:36 -0500 | Rating Details | |
2023-04-03 08:44:43 -0500 | Rating Details | |
2023-04-02 22:26:35 -0500 | Rating Details | |
2023-04-02 20:26:21 -0500 | Rating Details | |
2023-04-02 12:58:14 -0500 | Rating Details | |
2023-04-02 11:26:12 -0500 | Rating Details | |
2023-04-02 14:36:38 -0500 | Rating Details | |
2023-04-02 21:20:04 -0500 | Rating Details | |
2023-04-03 06:07:16 -0500 | Rating Details | |
2023-04-02 19:45:26 -0500 | Rating Details | |
2023-04-02 17:03:26 -0500 | Rating Details | |
2023-04-02 11:29:12 -0500 | Rating Details | |
2023-04-03 05:51:40 -0500 | Rating Details | |
2023-04-02 17:54:49 -0500 | Rating Details | |
2023-04-02 21:14:40 -0500 | Rating Details | |
2023-04-02 11:37:39 -0500 | Rating Details | |
2023-04-02 12:00:15 -0500 | Rating Details | |
2023-04-02 13:44:37 -0500 | Rating Details | |
2023-04-02 20:21:03 -0500 | Rating Details |